All-trans retinoic acid stimulates gene expression of the cardioprotective natriuretic peptide system and prevents fibrosis and apoptosis in cardiomyocytes of obese ob/ob mice

Applied Physiology, Nutrition and Metabolism

Volumn 39, Issue 10, 2014, Pages 1127-1136

  Manolescu, Daniel Constantin ^a   Jankowski, Marek ^a   Danalache, Bogdan A ^a   Wang, Donghao ^a   Broderick, Tom L ^b   Chiasson, Jean Louis ^a   Gutkowska, Jolanta ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Apoptosis; Cardiac fibrosis; Cardioprotection; Glycaemia; Lipolysis; Natriuretic peptides; Ob ob mice; Oxytocin; Retinoic acid; Visceral fat

Indexed keywords

NATRIURETIC FACTOR; RETINOIC ACID;

ANIMAL; APOPTOSIS; CARDIAC MUSCLE CELL; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; OBESITY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; MICE; MICE, OBESE; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDES; OBESITY; TRETINOIN;

EID: 84907811135     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2014-0005     Document Type: Article

References (53)

1. Alizadeh, A.M., Faghihi, M., Sadeghipour, H.R., Mohammadghasemi, F., Imani, A., Houshmand, F., and Khori, V. 2010. Oxytocin protects rat heart against ischemia-reperfusion injury via pathway involving mitochondrial ATP-dependent potassium channel. Peptides, 31(7): 1341–1345. doi:10.1016/j.peptides.2010.04.012.
2. Arceci, R.J., King, A.A., Simon, M.C., Orkin, S.H., and Wilson, D.B. 1993. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol. Cell. Biol. 13(4): 2235–2246.
3. Barouch, L.A., Gao, D., Chen, L., Miller, K.L., Xu, W., Phan, A.C., et al. 2006. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ. Res. 98(1): 119–124.
4. Bartels, E.D., Nielsen, J.M., Bisgaard, L.S., Goetze, J.P., and Nielsen, L.B. 2010. Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. Endocrinology, 151: 5218–5225.
5. Berry, D.C., DeSantis, D., Soltanian, H., Croniger, C.M., and Noy, N. 2012. Retinoic acid upregulates preadipocyte genes to block adipogenesis and suppress dietinduced obesity. Diabetes, 61(5): 1112–1121. doi:10.2337/db11-1620.
6. Bhat, P.V., and Lacroix, A. 1991. Effects of retinoic acid on the concentrations of radioactive metabolites of retinol in tissues of rats maintained on a retinoldeficient diet. Can. J. Physiol. Pharmacol. 69(6): 826–830. doi:10.1139/y91-124.
7. Bonet, M.L., Ribot, J., and Palou, A. 2012. Lipid metabolism in mammalian tissues and its control by retinoic acid. Biochim. Biophys. Acta, 1821(1): 177–189. doi:10.1016/j.bbalip.2011.06.001.
8. Bonet, M.L., Oliver, P., and Palou, A. 2013. Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim. Biophys. Acta, 1831(5): 969–985. doi:10.1016/j.bbalip.2012.12.002.
9. Bordicchia, M., Liu, D., Amri, E.Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., et al. 2012. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Investig. 122(3): 1022–1036. doi:10.1172/JCI59701.
10. Choudhary, R., Baker, K.M., and Pan, J. 2008a. All-trans retinoic acid prevents angiotensin II-and mechanical stretch-induced reactive oxygen species generation and cardiomyocyte apoptosis. J. Cell Physiol. 215(1): 172–181. doi:10.1002/jcp.21297.
11. Choudhary, R., Palm-Leis, A., Scott, R.C., III, Guleria, R.S., Rachut, E., Baker, K.M., and Pan, J. 2008b. All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system. Am. J. Physiol. Heart Circ. Physiol. 294(2): H633–H644. doi:10.1152/ajpheart.01301.2007.
12. Danalache, B.A., Paquin, J., Donghao, W., Grygorczyk, R., Moore, J.C., Mummery, C.L., et al. 2007. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells, 25(3): 679–688.
13. Deblon, N., Veyrat-Durebex, C., Bourgoin, L., Caillon, A., Bussier, A.L., Petrosino, S., et al. 2011. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PloS ONE, 6(9): e25565. doi:10.1371/journal.pone.0025565.
14. Eckertova, M., Ondrejcakova, M., Krskova, K., Zorad, S., and Jezova, D. 2011. Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis. Brit. J. Pharmacol. 162(2): 452–463. doi:10.1111/j.1476-5381.2010.01037.x.
15. Florian, M., Jankowski, M., and Gutkowska, J. 2010. Oxytocin increases glucose uptake in neonatal rat cardiomyocytes. Endocrinology, 151(2): 482–491. doi: 10.1210/en.2009-0624.
16. Gutkowska, J., Jankowski, M., Lambert, C., Mukaddam-Daher, S., Zingg, H.H., and McCann, S.M. 1997. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc. Natl. Acad. Sci. U.S.A. 94(21): 11704–11709. doi:10.1073/pnas.94.21.11704.
17. Gutkowska, J., Paquette, A., Wang, D., Lavoie, J.-M., and Jankowski, M. 2007. Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293(1): R267–R275. doi:10.1152/ajpregu.00071.2007.
18. Gutkowska, J., Broderick, T.L., Bogdan, D., Wang, D., Lavoie, J.M., and Jankowski, M. 2009. Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy. J. Physiol. 587(Pt 19): 4725–4736. doi:10.1113/jphysiol.2009.176461.
19. He, Y., Huang, Y., Zhou, L., Lu, L.M., Zhu, Y.C., and Yao, T. 2006. All-trans retinoic acid inhibited angiotensin II-induced increase in cell growth and collagen secretion of neonatal cardiac fibroblasts. Acta Pharmacol. Sin. 27(4): 423–429. doi:10.1111/j.1745-7254.2006.00296.x.
20. Hindle, A.K., Edwards, C., McCaffrey, T., Fu, S., and Brody, F. 2010. Identification of cardiovascular genes in omentum from morbidly obese patients with type 2 diabetes. Int. J. Obes. (Lond.), 34(6): 1020–1027. doi:10.1038/ijo.2010.23.
21. Huang, Y., Wright, C.D., Kobayashi, S., Healy, C.L., Elgethun, M., Cypher, A., et al. 2008. GATA4 is a survival factor in adult cardiac myocytes but is not required for Δ1A-adrenergic receptor survival signaling. Am. J. Physiol. Heart Circ. Physiol. 295(2): H699–H707. doi:10.1152/ajpheart.01204.2007.
22. Ignarro, L.J., Cirino, G., Casini, A., and Napoli, C. 1999. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardio. Pharmacol. 34(6): 879–886. doi:10.1097/00005344-199912000-00016.
23. Jankowski, M., Danalache, B., Wang, D., Bhat, P., Hajjar, F., Marcinkiewicz, M., et al. 2004. Oxytocin in cardiac ontogeny. Proc. Natl. Acad. Sci. U.S.A. 101(35): 13074–13079. doi:10.1073/pnas.0405324101.
24. Jankowski, M., Wang, D., Danalache, B., Gangal, M., and Gutkowska, J. 2010a. Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 299(2): H265–H274. doi:10.1152/ajpheart.00487.2009.
25. Jankowski, M., Bissonauth, V., Gao, L., Gangal, M., Wang, D., Danalache, B., et al. 2010b. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res. Cardiol. 105(2): 205–218. doi:10.1007/s00395-009-0076-5.
26. Kobayashi, H., Yasuda, S., Bao, N., Iwasa, M., Kawamura, I., Yamada, Y., et al. 2009. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis. J. Cardiovasc. Pharmacol. 54(6): 510–519. doi:10.1097/FJC.0b013e3181bfac02.
27. Kobayashi, S., Mao, K., Zheng, H., Wang, X., Patterson, C., O’Connell, T.D., and Liang, Q. 2007.DiminishedGATA4protein levels contribute to hyperglycemiainduced cardiomyocyte injury. J. Biol. Chem. 282(30): 21945–21952. doi:10. 1074/jbc.M703048200.
28. Lü, L., Yao, T., Zhu, Y.-Z., Huang, G.-Y., Cao, Y.-X., and Zhu, Y.-C. 2003. Chronic all-trans retinoic acid treatment prevents medial thickening of intramyocardial and intrarenal arteries in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 285(4): H1370–H1377.
29. Lundgren, M., Svensson, M., Lindmark, S., Renström, F., Ruge, T., and Eriksson, J.W. 2007. Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’. Diabetologia, 50(3): 625–633. doi:10.1007/s00125-006-0572-1.
30. Manolescu, D.C., Sima, A., and Bhat, P.V. 2010. All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice. J. Nutr. 140(2): 311–316. doi:10.3945/jn.109.115147.
31. Mazumder, P.K., O’Neill, B.T., Roberts, M.W., Buchanan, J., Yun, U.J., Cooksey, R.C., et al. 2004. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes, 53(9): 2366–2374. doi:10.2337/diabetes.53.9.2366.
32. Miyashita, K., Itoh, H., Tsujimoto, H., Tamura, N., Fukunaga, Y., Sone, M., et al. 2009. Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes, 58(12): 2880–2892. doi:10.2337/db09-0393.
33. Moro, C. 2013. Natriuretic peptides and fat metabolism. Curr. Opin. Clin. Nutr. Metab. Care, 16(6): 645–649. doi:10.1097/MCO.0b013e32836510ed.
34. Moro, C., Crampes, F., Sengenes, C., De Glisezinski, I., Galitzky, J., Thalamas, C., et al. 2004. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J. 18(7): 908–910. doi:10.1096/fj.03-1086fje.
35. Myhre, A.M., Takahashi, N., Blomhoff, R., Breitman, T.R., and Norum, K.R. 1996. Retinoylation of proteins in rat liver, kidney, and lung in vivo. J. Lipid Res. 37(9): 1971–1977.
36. Paiva, S.A., Matsubara, L.S., Matsubara, B.B., Minicucci, M.F., Azevedo, P.S., Campana, A.O., and Zornoff, L.A. 2005. Retinoic acid supplementation attenuates ventricular remodeling after myocardial infarction in rats. J. Nutr. 135(10): 2326–2328.
37. Pan, J., and Baker, K.M. 2007. Retinoic acid and the heart. Vitam. Horm. 75: 257–283. doi:10.1016/S0083-6729(06)75010-5.
38. Plante, E., Menaouar, A., Danalache, B.A., Broderick, T.L., Jankowski, M., and Gutkowska, J. 2014. Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice. Diabetologia, 57(6): 1257–1267. doi:10.1007/s00125-014-3201-4.
39. Reichert, B., Yasmeen, R., Jeyakumar, S.M., Yang, F., Thomou, T., Alder, H., et al. 2011. Concerted action of aldehyde dehydrogenases influences depot-specific fat formation. Mol. Endocrinol. 25(5): 799–809. doi:10.1210/me.2010-0465.
40. Rysa, J., Tenhunen, O., Serpi, R., Soini, Y., Nemer, M., Leskinen, H., and Ruskoaho, H. 2010. GATA-4 is an angiogenic survival factor of the infracted heart. Circ. Heart Failure, 3(3): 440–450. doi:10.1161/CIRCHEARTFAILURE.109.889642.
41. Schmieder, R.E., and Messerli, F.H. 1987. Obesity hypertension. The Medical Clinics of North America, 71(5): 991–1001.
42. Szeto, A., Nation, D.A., Mendez, A.J., Dominguez-Bendala, J., Brooks, L.G., Schneiderman, N., and McCabe, P.M. 2008. Oxytocin attenuates NADPHdependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am. J. Physiol. Endocrinol. Metab. 295(6): E1495–E1501. doi:10.1152/ajpendo.90718.2008.
43. Tamura, N., Ogawa, Y., Chusho, H., Nakamura, K., Nakao, K., Suda, M., et al. 2000. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. U.S.A. 97(8): 4239–4244. doi:10.1073/pnas.070371497.
44. Trivedi, P., Yang, R., and Barouch, L.A. 2008. Decreased p110_ catalytic activity accompanies increased myocyte apoptosis and cardiac hypertrophy in leptin deficient ob/ob mice. Cell Cycle, 7(5): 560–565. doi:10.4161/cc.7.5.5529.
45. Uchida, S., Fuke, S., and Tsukahara, T. 2007. Upregulations of Gata4 and oxytocin receptor are important in cardiomyocyte differentiation processes of P19CL6 cells. J. Cell. Biochem. 100(3): 629–641. doi:10.1002/jcb.21094.
46. Uruno, A., Sugawara, A., Kanatsuka, H., Kagechika, H., Saito, A., Sato, K., et al. 2005. Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/Akt pathway. Circulation, 112(5): 727–736. doi:10.1161/CIRCULATIONAHA.104.500959.
47. Van den Bergh, A., Vanderper, A., Vangheluwe, P., Desjardins, F., Nevelsteen, I., Verreth, W., et al. 2008. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc. Res. 77(2): 371–379. doi:10.1093/cvr/cvm001.
48. Wang, H.J., Zhu, Y.C., and Yao, T. 2002. Effects of all-trans retinoic acid on angiotensin II-induced myocyte hypertrophy. J. Appl. Physiol. 92(5): 2162–2168.
49. Whittle, A.J., and Vidal-Puig, A. 2012. NPs – heart hormones that regulate brown fat? J. Clin. Invest. 122(3): 804–807. doi:10.1172/JCI62595.
50. Wu, J., Garami, M., Cheng, T., and Gardner, D.G. 1996. 1, 25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J. Clin. Invest. 97(7): 1577–1588. doi:10.1172/JCI118582.
51. Zhang, G., and Cai, D. 2011. Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment. Am. J. Physiol. Endocrinol. Metab. 301(5): E1004–E1012. doi:10.1152/ajpendo.00196.2011.
52. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J.M. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature, 372(6505): 425–432. doi:10.1038/372425a0.
53. Zhou, M.D., Sucov, H.M., Evans, R.M., and Chien, K.R. 1995. Retinoid-dependent pathways suppress myocardial cell hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 92(16): 7391–7395. doi:10.1073/pnas.92.16.7391.